共 50 条
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry
被引:4
|作者:
Ozdemir, Zehra Narli
[1
,5
]
Falay, Mesude
[2
]
Parmaksiz, Ayhan
[3
]
Genc, Eylem
[1
]
Beyler, Ozlem
[1
]
Gunes, Ahmet Kursad
[1
]
Ceran, Funda
[1
]
Dagdas, Simten
[1
]
Ozet, Gulsum
[4
]
机构:
[1] Ankara City Hosp, Ankara, Turkiye
[2] Duzen Labs Grp, Ankara, Turkiye
[3] Istanbul Hlth & Technol Univ, Istanbul, Turkiye
[4] Yildirim Beyazit Univ, Sch Med, Ankara, Turkiye
[5] Ankara City Hosp, Dept Hematol, Univ,Bilkent Blv 1, TR-06800 Cankaya, Ankara, Turkiye
关键词:
Chronic lymphocytic leukemia;
Flow cytometry;
Hierarchical logistic regression;
model;
SCORING SYSTEM;
TREE APPROACH;
CLASSIFICATION;
LYMPHOMA;
D O I:
10.1016/j.htct.2021.08.012
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Introduction: The availability of a clinical decision algorithm for diagnosis of chronic lymphocytic leukemia (CLL) may greatly contribute to the diagnosis of CLL, particularly in cases with ambiguous immunophenotypes. Herein we propose a novel differential diagnosis algorithm for the CLL diagnosis using immunophenotyping with flow cytometry. Methods: The hierarchical logistic regression model (Backward LR) was used to build a predictive algorithm for the diagnosis of CLL, differentiated from other lymphoproliferative disorders (LPDs). Results: A total of 302 patients, of whom 220 (72.8%) had CLL and 82 (27.2%), B-cell lymphoproliferative disorders other than CLL, were included in the study. The Backward LR model comprised the variables CD5, CD43, CD81, ROR1, CD23, CD79b, FMC7, sIg and CD200 in the model development process. The weak expression of CD81 and increased intensity of expression in markers CD5, CD23 and CD200 increased the probability of CLL diagnosis, (p < 0.05). The odd ratio for CD5, C23, CD200 and CD81 was 1.088 (1.050 - 1.126), 1.044 (1.012 1.077), 1.039 (1.007 - 1.072) and 0.946 (0.921 - 0.970) [95% C.I.], respectively. Our model provided a novel diagnostic algorithm with 95.27% of sensitivity and 91.46% of specificity. The model prediction for 97.3% (214) of 220 patients diagnosed with CLL, was CLL and for 91.5% (75) of 82 patients diagnosed with an LPD other than CLL, was others. The cases were correctly classified as CLL and others with a 95.7% correctness rate. Conclusions: Our model highlighting 4 markers (CD81, CD5, CD23 and CD200) provided high sensitivity and specificity in the CLL diagnosis and in distinguishing of CLL among other LPDs. Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license
引用
收藏
页码:176 / 181
页数:6
相关论文